Author:
Engle J C,Lifland P W,Schleupner C J
Abstract
Ceftazidime and cefamandole were compared in the treatment of pneumonia. The median MIC of ceftazidime for all Streptococcus pneumoniae (n = 17) and Haemophilus influenzae (n = 10) isolates was 0.125 microgram/ml. All other isolates were inhibited by less than 0.5 microgram of ceftazidime per ml, with the exception of a group B streptococcus (MIC = 4 micrograms/ml). Satisfactory clinical responses were observed in 91% (20 of 22) of cefamandole-treated patients and 85% (17 of 20) of ceftazidime-treated patients.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference33 articles.
1. Effects of moxalactam on blood coagulation and platelet function;Bang N. U.;Rev. Infect. Dis.,1982
2. Antibiotic susceptibility testing by a standardized single disk method;Bauer A. W.;Am. J. Clin. Pathol.,1966
3. Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms;Clumeck N.;Antimicrob. Agents Chemother.,1983
4. Effect of cefamandole nafate on blood coagulation and platelet function;Custer G. M.;Antimicrob. Agents Chemother.,1979
5. Ericsson H. M. and J. C. Sherris. 1971. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol. Microbiol. Scand. Sect. B p. 217(Suppl.).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献